DataMeds AI, Inc. Selling and Marketing Expense
DataMeds AI, Inc. (MEDS) reported Selling and Marketing Expense of $113.99 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-17
- DataMeds AI, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $113.99K, a 66.80% decline year-over-year.
- DataMeds AI, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $960.00K, a 1372.01% increase year-over-year.
- DataMeds AI, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $12.17K.
- DataMeds AI, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $803.75K.
- DataMeds AI, Inc. selling and marketing expense for fiscal 2025 was $1.22M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $113.99K 10-Q · filed 2026-08-17 | $1.07M 10-Q · filed 2026-08-17 | $1.09M derived: sum of 3 quarters · filed 2026-08-17 | $1.89M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $960.00K 10-Q · filed 2026-05-19 | $972.17K derived: sum of 2 quarters · filed 2026-05-19 | $1.78M derived: sum of 3 quarters · filed 2026-05-19 | $2.12M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $12.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $815.92K derived: sum of 2 quarters · filed 2026-03-20 | $1.16M derived: sum of 3 quarters · filed 2026-08-17 | $1.22M 10-K · filed 2026-03-20 |
| 2025-09-30 | $803.75K 10-Q · filed 2025-11-19 | $1.15M derived: sum of 2 quarters · filed 2026-08-17 | $1.21M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $343.38K 10-Q · filed 2026-08-17 | $408.60K 10-Q · filed 2026-08-17 | ||
| 2025-03-31 | $65.22K 10-Q · filed 2026-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |